Trials / Conditions / Progeria
Progeria
6 registered clinical trials studyying Progeria — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria NCT02579044 | Boston Children's Hospital | Phase 1 / Phase 2 |
| Unknown | Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria NCT00916747 | Boston Children's Hospital | Phase 2 |
| Completed | A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria NCT00879034 | Boston Children's Hospital | Phase 2 |
| Completed | Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria NCT00425607 | Monica E. Kleinman | Phase 2 |
| Completed | Clinical Studies of Progeria NCT00094393 | National Human Genome Research Institute (NHGRI) | — |
| Approved For Marketing | Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy NCT03895528 | Eiger BioPharmaceuticals | — |